The share varies from a low of 70 percent in the District of Columbia to a high of 94 percent in Idaho to a low of 70 percent in the District of Columbia. The analysis of data from the Centers for Disease Control and Prevention provides clear evidence of the toll that the novel coronavirus has taken on older Americans. It also provides a more detailed picture of where the impact on seniors has been the greatest.
Private insurers typically pay more than twice as much as Medicare for services likely to be used by patients hospitalized with COVID-19. Our analysis also shows there is much wider variation in private insurance payment rates than Medicare payments for all services we analyzed.
Hospitals and other providers are asking Congress for more time to repay — or even forgive — the $100 billion in Medicare accelerated and advance payments that eased the blow of the COVID-19 pandemic. We explain the programs and the implications of modifying repayment terms.
While the out-of-pocket cost to Medicare COVID-19 patients will not change under any current or future pricing scenario for remdesivir as long as it is provided as part of an inpatient hospital stay, the drug’s price — currently $3,120 for hospitals –matters to public programs and private payers.
Even before the effects of the coronavirus pandemic are fully realized, our analysis finds many Medicare beneficiaries lived on limited incomes and modest, if any, savings, with wide disparities by age, gender and race/ethnicity. That raises questions about the extent to which Medicare beneficiaries will be able to bear additional, unanticipated costs that are likely to arise from the pandemic.
Congress, the Trump Administration and the Biden campaign have all proposed ways to lower prescription drug costs. Our chartpack summarizes key elements in these proposals and their likely impact on prices, people and federal spending.
A relatively small share of people with Medicare Advantage or stand-alone Medicare Part D prescription drug coverage voluntarily switch plans during Medicare’s open enrollment period from Oct. 15 to Dec. 7.